Chronisch Lymphatische Leukämie Guidline and Quality indicator
0.2.0 - ci-build

Chronisch Lymphatische Leukämie Guidline and Quality indicator - Local Development build (v0.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

PlanDefinition: QI 5: Bcl-2- oder BTK-Inhibitor-basierten Therapie als Erstlinientherapie (neu 2024) - Testing

Active as of 2024-07

Test Plans

No test plans are currently available for the PlanDefinition.

Test Scripts

No test scripts are currently available for the PlanDefinition.